Jin Medical Showcases Innovation Across Four Global Industry Expos: Lightweight Rehabilitation Assistive Line Draws Broad Market Attention

Marking its 20th anniversary, the company completes a four-stop market tour across the Yangtze River Delta, Beijing-Tianjin-Hebei, ASEAN, and Europe, steadily advancing its global footprint.

CHANGZHOU, China, Nov. 2, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment announced today its steady expansion in the global market. From August to September 2026, Jin Medical participated in four leading rehabilitation and assistive technology expos at home and abroad: REHACARE CHINA 2026 (Suzhou, China), the Care & Rehabilitation Expo China 2026 (CR Expo) (Beijing, China), the 23rd China-ASEAN Expo (CAEXPO) (Nanning, China), and REHACARE 2026 (Düsseldorf, Germany). Throughout the exhibition tour, the company presented its full lineup of new manual and power wheelchairs, conducting high-level business engagements centered around two strategic pillars: domestic distribution expansion and international dealer network development.

The year 2026 marks the 20th anniversary of Changzhou Jin Medical Products Co., Ltd. The company noted that participating in these four major exhibitions consecutively represents a concentrated showcase of two decades of R&D and technological expertise across global markets. It also serves as an operational execution of the company's annual theme: "Twenty Years of Shared Journey, Embarking Anew for Sustainable Growth."

I. REHACARE CHINA 2026 (Suzhou): The Journey Begins with Targeted Industry Chain Engagement

From August 20 to 22, REHACARE CHINA 2026 (Rehabilitation Equipment and Solutions Exhibition) was held at the Suzhou International Expo Centre. Organized by Messe Düsseldorf (Shanghai) Co., Ltd. under the theme "Empowering Through Innovation, Integrating for Renewal," the exhibition serves as a specialized platform bridging international rehabilitation solutions with the Chinese market.

Leveraging its accumulated technical expertise in lightweight engineering and compact folding mechanisms, Jin Medical exhibited its comprehensive portfolio of newly developed manual and power wheelchairs. During the event, the company engaged visitors through a blend of physical product displays and hands-on test-drives, exchanging detailed insights on clinical and daily usability. The craftsmanship, human-centric design, and maneuverability of the new models garnered widespread recognition among attending professionals.

II. Care & Rehabilitation Expo China 2026 (Beijing): Comprehensive Product Matrix on Display

From September 3 to 5, the 2026 Care & Rehabilitation Expo China (CR Expo) took place at the China National Convention Center in Beijing. Hosted by the China Disabled Persons' Federation under the theme "Empowering Through Technology, Sharing Well-being," the exhibition spanned roughly 28,000 square meters and brought together 504 enterprises and institutions from across the globe.

Jin Medical showcased its full product matrix at CR Expo, highlighting two primary technical trajectories:

• Manual Wheelchair Line: Centered on lightweight engineering, these models feature integrated full-carbon fiber frames that significantly reduce overall curb weight while preserving structural integrity. Paired with ergonomic design, they are purpose-built to overcome mobility barriers in confined public environments—such as aircraft cabins and airport security checkpoints. Furthermore, this ultra-lightweight approach transcends the conventional boundaries of assistive gear, allowing devices to integrate seamlessly into daily lifestyle routines like personal carry-ons and redefining the role of mobility aids.
• Electric Wheelchair Line: Guided by smart technology, this line integrates intelligent control architectures and proprietary drive algorithms to deliver optimized throttle response, intelligent battery management, and enhanced functional safety. In terms of industrial design, the products adopt clean, streamlined contours, unified chassis architecture, and balanced color palettes. By harmonizing functional components with aesthetic elegance, the designs cater to diverse cultural preferences and lifestyles while de-emphasizing the traditional institutional, clinical look of medical mobility equipment.

Throughout the event, Jin Medical operated an interactive trial zone. Domestic distributors and end-users held in-depth discussions with the company after test-driving the equipment,  with several dealers expressing interest in exploring potential cooperation.

III. The 23rd China-ASEAN Expo (Nanning): Tailored Product Demonstrations for Southeast Asian Markets

From September 17 to 21, the 23rd China-ASEAN Expo (CAEXPO) was hosted in Nanning, Guangxi, under the theme "Sharing Opportunities in Free Trade Area 3.0, Creating a Better Life Together." The expo convened during a pivotal year marking the implementation phase following the signing of the ASEAN-China Free Trade Area (ACFTA) 3.0 Upgrade Protocol.

To meet the regional characteristics of compact living spaces and diverse urban transit scenarios in ASEAN households, Jin Medical highlighted ultra-compact folding wheelchairs engineered for effortless transport and easy maintenance. Visiting clients and procurement delegates from across Southeast Asia engaged in constructive dialogues with company representatives regarding lightweight portability, everyday convenience, and long-term durability.

IV. REHACARE 2026 (Düsseldorf, Germany): Closing the International Tour on a High Note

From September 23 to 26, REHACARE 2026 took place in Düsseldorf, Germany. As one of the world's premier trade fairs for rehabilitation, prevention, inclusion, and care, this edition centered on the theme "Independent Living." Official figures reported that the event attracted nearly 1,000 exhibitors from 43 countries and welcomed approximately 45,000 trade visitors across 101 nations.

Jin Medical brought its flagship models to Düsseldorf, successfully concluding its four-stop tour. Throughout the show, distributors from Europe, the Middle East, and Southeast Asia commended the products' manufacturing precision and ergonomic design. Following test-drives, several potential international partners engaged in preliminary discussions regarding possible distribution arrangements. The exhibition significantly elevated Jin Medical's brand presence across Europe, laying a solid foundation for the continued expansion of its global distribution channels.

Europe represents one of the most mature rehabilitation assistive device markets worldwide, where end-users and institutional buyers demand exacting standards in precision engineering, material tactile quality, and design language, alongside stringent regulatory compliance and market access protocols. The direct feedback received from European industry professionals served not only as a rigorous external validation of Jin Medical's manufacturing capabilities and design philosophy, but also provided key benchmarks for upcoming product iterations and localized adaptations.

Notably, REHACARE 2026 in Düsseldorf and REHACARE CHINA 2026 in Suzhou both operate under the auspices of Messe Düsseldorf Group. Opening in Suzhou and concluding in Düsseldorf created a strategic closed-loop within the same premier international exhibition ecosystem. This alignment enabled Jin Medical's product offerings to be evaluated and benchmarked under a cohesive global standard by professional audiences across both domestic and overseas markets.

V. Customer Feedback: Core Focus on Lightweight Design and Handling Stability

Across all four exhibitions, Jin Medical emphasized real-world trial experiences as its primary engagement method. Feedback consolidated across domestic distributors, ASEAN buyers, eldercare institutions, and European dealers revealed consistent market priorities: ultra-lightweight build, intuitive maneuverability, and reliable operational stability.

VI. Jin Medical: Embarking on the Next Twenty Years

Founded in 2006, Jin Medical has remained dedicated to the eldercare and rehabilitation industries since its inception. Through twenty years of disciplined development and technical accumulation, the company has grown into a high-tech enterprise of significant influence in China's rehabilitation equipment sector, specializing in the research, manufacturing, and commercial application of mid-to-high-end mobility devices. Its products are exported to more than 90 countries and regions worldwide, including Japan, Europe, the Americas, and Southeast Asia. The enthusiastic reception of these new models and the growing interest from potential distribution partners stand as strong validation of Jin Medical's two decades of dedication.

Standing at this 20-year milestone, Jin Medical will continue to drive forward with technological innovation and globalization, further broadening its footprint across domestic and international markets. The company remains committed to providing global users with professional, precise, and efficient rehabilitation devices and integrated mobility solutions, contributing to the high-quality development of the global assistive technology industry.

About Jin Medical International Ltd.

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical's wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.zhjmedical.com.

Forward-Looking Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may", "will", "should", "intend", "plan", "strive",  "believe", "expect", "anticipate", "project", "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company's ability to achieve its goals and strategies, the Company's future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission ("SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:
[email protected]

SOURCE Jin Medical International Ltd.